Literature DB >> 23512699

Apoptosis: its role in pituitary development and neoplastic pituitary tissue.

M F Guzzo1, L R S Carvalho, M D Bronstein.   

Abstract

Apoptosis, also known as programmed cell death, is a phenomenon in which different stimuli trigger cellular mechanisms that culminate in death, in the absence of inflammatory cell response. Two different activation pathways are known, the intrinsic pathway (or mitochondrial) and extrinsic (or death-receptor pathway), both pathways trigger enzymatic reactions that lead cells to break up and be phagocytized by neighboring cells. This process is a common occurrence in physiological and pathological states, participating in the control of cell proliferation, differentiation and remodeling of organs. In the early steps of pituitary gland formation, numerous apoptotic cells are detected in the separation of Rathke's pouch from the roof of oral ectoderm. In the distal part of the gland, which will form the adenohypophysis, the ratio of apoptosis was significantly lower. However, there is evidence that neoplastic pituitary cells undergo unbalance in genes that control apoptosis leading to uncontrolled cell growth. No direct evidence of apoptosis was found in the drugs used for tumors producing prolactin and growth hormone. In conclusion, an unbalancing in the apoptosis process is the boundary between development and tumor growth.

Entities:  

Mesh:

Year:  2014        PMID: 23512699     DOI: 10.1007/s11102-013-0481-5

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  27 in total

Review 1.  Predictive markers of pituitary adenoma behavior.

Authors:  George Kontogeorgos
Journal:  Neuroendocrinology       Date:  2006-10-13       Impact factor: 4.914

Review 2.  [Pituitary tumorigenesis].

Authors:  Marcello D Bronstein; Shlomo Melmed
Journal:  Arq Bras Endocrinol Metabol       Date:  2006-01-23

3.  Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.

Authors:  Maria Chiara Zatelli; Mariella Minoia; Carlo Filieri; Federico Tagliati; Mattia Buratto; Maria Rosaria Ambrosio; Marcello Lapparelli; Massimo Scanarini; Ettore C Degli Uberti
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

Review 4.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

5.  Correlation of bcl-2 and bax with apoptosis in human pituitary adenomas.

Authors:  Demetrios Sambaziotis; Nikiforos Kapranos; George Kontogeorgos
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

6.  Apoptosis in the anterior pituitary gland of the rat: studies with estrogen and bromocriptine.

Authors:  N Drewett; J M Jacobi; D A Willgoss; H M Lloyd
Journal:  Neuroendocrinology       Date:  1993-01       Impact factor: 4.914

Review 7.  [Molecular aspects of pituitary tumorigenesis].

Authors:  Emilia M Pinto; Marcello D Bronstein
Journal:  Arq Bras Endocrinol Metabol       Date:  2008-06

8.  Cell proliferation and vascularization in mouse models of pituitary hormone deficiency.

Authors:  Robert D Ward; Brandon M Stone; Lori T Raetzman; Sally A Camper
Journal:  Mol Endocrinol       Date:  2006-03-23

9.  RGD-FasL induces apoptosis of pituitary adenoma cells.

Authors:  Lukui Chen; Guohong Zhuang; Wenzhu Li; Yunsheng Liu; Junqing Zhang; Xinhua Tian
Journal:  Cell Mol Immunol       Date:  2008-02       Impact factor: 11.530

10.  The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma.

Authors:  Anna Gruszka; Jolanta Kunert-Radek; Marek Pawlikowski
Journal:  Folia Histochem Cytobiol       Date:  2004       Impact factor: 1.698

View more
  6 in total

1.  Opposite effects of dihydrotestosterone and estradiol on apoptosis in the anterior pituitary gland from male rats.

Authors:  María Laura Magri; María Florencia Gottardo; Sandra Zárate; Guadalupe Eijo; Jimena Ferraris; Gabriela Jaita; Mariela Moreno Ayala; Marianela Candolfi; Daniel Pisera; Adriana Seilicovich
Journal:  Endocrine       Date:  2015-08-22       Impact factor: 3.633

2.  Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma.

Authors:  Cristiana Tanase; Radu Albulescu; Elena Codrici; Bogdan Calenic; Ionela Daniela Popescu; Simona Mihai; Laura Necula; Maria Linda Cruceru; Mihail Eugen Hinescu
Journal:  Onco Targets Ther       Date:  2014-12-22       Impact factor: 4.147

Review 3.  Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas.

Authors:  Na Li; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

4.  Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas.

Authors:  Mohammad E Khamseh; Alireza Sheikhi; Zahra Shahsavari; Mohammad Ghorbani; Hamideh Akbari; Mehrnaz Imani; Mahshid Panahi; Alimohammad Alimohammadi; Maryam Ameri; Shima Nazem; Vahid Salimi; Masoumeh Tavakoli-Yaraki
Journal:  BMC Endocr Disord       Date:  2022-01-04       Impact factor: 2.763

Review 5.  Architects of Pituitary Tumour Growth.

Authors:  Maria Eugenia Sabatino; Ezequiel Grondona; Ana Lucía De Paul
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

6.  miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.

Authors:  Min Bao; Yingjian Song; Jingjing Xia; Pengling Li; Qing Liu; Zongren Wan
Journal:  Onco Targets Ther       Date:  2018-03-26       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.